Enveric Biosciences, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

Latest Posts

About This Stock More About This Stock
S Year-End Summary: Marijuana & Psychedelic Compounds-Based Drug Stocks Index Went DOWN -33.6% In 2021!
Article By: Lorimer Wilson
Sunday, January 2, 2022 2:40 AM EDT
Which index performed the best in 2021, the Marijuana Drug Stocks Index, or the Psychedelic Compounds-Based Drug Stocks Index? Which constituents contributed to their performances? This article has the answers.
In this article: ATAI, CMPS, MYCOF, ENVB, GHRS
Read
S Cannabis & Psychedelic Compound-Based Drug Stocks Continue To Decline
Article By: Lorimer Wilson
Sunday, December 12, 2021 11:46 AM EDT
The six marijuana-based clinical-stage stocks are down 31.1% since the end of June; the 9 psychedelic compound-based clinical-stage stocks with market caps under $1B are down 36.3% in that same timeframe.
In this article: LKYSF, ATAI, CMPS, MYCOF, TRUFF, ENVB, GHRS, ALID
Read
Nasdaq Welcomes New Psychedelics Company In $23M M&A Transaction
Article By: Benzinga
Friday, September 17, 2021 3:55 PM EDT
The psychedelics sector has closed one of its largest M&As since its inception.
In this article: ENVB
Read
S Cannabis And Psychedelic Drug Stock Performances Were Mixed Last Week
Article By: Lorimer Wilson
Saturday, September 11, 2021 7:32 AM EDT
The performance of the psychedelic-focused index components substantially outshone the weed stocks.
In this article: RVVTF, MYCOF, FTRPF, ENVB, ALID, AWKNF
Read
S Marijuana Drug Stocks: All You Need To Know
Article By: Lorimer Wilson
Friday, August 13, 2021 4:53 AM EDT
Eight clinical-stage companies are researching the treatment of a wide variety of illnesses using marijuana. Six have market capitalizations between $50M and $500M; two are between $37M-$50M.
In this article: ZYNE, CRBP, RVVTF, TBPMF, MGCLF, ZLDAF, ENVB, ALID
Read

Latest Tweets for $ENVB

No tweets yet!

PARTNER HEADLINES